{"entity":{"id":"nicola-normanno","kind":"person","name":"Nicola Normanno","aka":[],"tldr":"Nicola Normanno represents IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST) in the Organisation of European Cancer Institutes, which lists the centre among its members in Italy.","summary":"Nicola Normanno is listed by the Organisation of European Cancer Institutes (OECI) as the representative of IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST), its full member in Italy. OnCo records the name from the OECI membership list so that the centre's page names its contact within Europe's cancer-centre network; the person's clinical or management role is not stated by the list and should be checked at the institution's website.","asOf":"2026-09-10","links":[{"label":"OECI membership list","url":"https://www.oeci.eu/Membership.aspx"},{"label":"IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST) website","url":"https://www.irst.emr.it"}],"tags":["oeci-representative","leader"],"related":["oeci"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["irst-meldola"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Representative of IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST) to the Organisation of European Cancer Institutes","institutionId":"irst-meldola","specialisms":["Cancer centre representation (OECI)"],"profiles":[{"label":"OECI membership list","url":"https://www.oeci.eu/Membership.aspx"},{"label":"IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST) website","url":"https://www.irst.emr.it"}],"papers":[{"title":"Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group","journal":"Ann Oncol","year":2024,"url":"https://doi.org/10.1016/j.annonc.2024.04.005","doi":"10.1016/j.annonc.2024.04.005","note":"Europe PMC author record matched by affiliation"},{"title":"EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey","journal":"J Thorac Oncol","year":2015,"url":"https://doi.org/10.1097/jto.0000000000000422","doi":"10.1097/jto.0000000000000422","note":"Europe PMC author record matched by affiliation"},{"title":"Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE Trial","journal":"JAMA Oncol","year":2021,"url":"https://doi.org/10.1001/jamaoncol.2021.2915","doi":"10.1001/jamaoncol.2021.2915","note":"Europe PMC author record matched by affiliation"}]},"route":"/people/nicola-normanno/","neighbours":{"institution":[{"id":"irst-meldola","kind":"institution","name":"IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST)","route":"/institutions/irst-meldola/"},{"id":"oeci","kind":"institution","name":"Organisation of European Cancer Institutes","route":"/institutions/oeci/"}]}}